PAVMライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:27):

Stats
本日の出来高	25 226.00
平均出来高	62 633.00
時価総額	16.28M
EPS	$-1.810 ( 2024-03-26 )
次の収益日	( $-1.890 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.0210 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Baxter Timothy E	Buy	65 000	Common stock
2024-02-22	White Debra	Buy	65 000	Common stock
2024-02-22	Sparks Ronald M	Buy	65 000	Common stock
2024-02-22	Harvey Joan B	Buy	65 000	Common stock
2024-02-22	Glennon Michael J	Buy	65 000	Common stock

INSIDER POWER
99.89
Last 94 transactions
Buy: 11 877 994 \| Sell: 5 035 719

ボリューム相関

長: 0.17 (neutral)

短: 0.52 (weak)

Signal:(59.328) Neutral

PAVmed Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PAVmed Inc 相関 - 通貨/商品

-0.23
( neutral )

-0.51
( weak negative )

0.00
( neutral )

-0.05
( neutral )

-0.39
( neutral )

PAVmed Inc 財務諸表

Annual	2023
収益:	$2.45M
総利益:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
収益:	$2.45M
総利益:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
収益:	$377 000
総利益:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
収益:	$500 000
総利益:	$-85 000.00 (-17.00 %)
EPS:	$-1.070

Financial Reports:

No articles found.

PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.